Sinopharm Group Co. Ltd. (1099.HK)
-HKSE 23.35 
0.20(0.86%) May 16
| Prev Close: | 23.15 |
|---|
| Open: | 23.00 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 22.05 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 22.85 - 23.45 |
|---|
| 52wk Range: | 16.76 - 28.10 |
|---|
| Volume: | 5,034,678 |
|---|
| Avg Vol (3m): | 4,820,090 |
|---|
| Market Cap: | 23.21B |
|---|
| P/E (ttm): | 22.85 |
|---|
| EPS (ttm): | 1.02 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in HKD.
Headlines
- Chinese Stocks Going Nowhere Fast, JPMorgan Saysat Barrons.com(Wed, May 15)
- Sinopharm first quarter net profit up 18 pct at 143.7 bln yuanat Reuters(Thu, Apr 25)
- Q1 2013 SINOPHARM GROUP CO. LTD. Earnings Release - Time Not SuppliedCCBN(Thu, Apr 25)
- PRESS DIGEST - Hong Kong - April 2at Reuters(Mon, Apr 1)
- China Biotech Week In Review: GE To Double Production In China By End Of 2015at Seeking Alpha(Sun, Mar 31)
- Sinopharm Falls on $515 Million Share-Sale Plan: Hong Kong Moverat Bloomberg(Thu, Mar 28)
- Sinopharm to raise up to $515 mln in share sale to fund expansionat Reuters(Wed, Mar 27)
- Sinopharm says 2012 net profit up 26 pct at 1.97 bln yuanat Reuters(Sun, Mar 24)
- FY 2012 SINOPHARM GROUP CO. LTD. Earnings Release - Time Not SuppliedCCBN(Fri, Mar 22)
- Hong Kong Stocks Rise on U.S. Stimulus, China GDP Targestat Bloomberg(Mon, Mar 4)
- China National Biotec Is Said to Plan $1.5 Billion Hong Kong IPOat Bloomberg(Sun, Jan 13)
- Emerging Stocks Retreat From Valuations at September Highat Bloomberg(Mon, Jan 7)
- Mizuho’s New China Fund to Focus on Reform as Leadership Changesat Bloomberg(Thu, Nov 8)
- Fosun Pharma Raises $512 Million in Offering at Bottom of Rangeat Bloomberg(Tue, Oct 23)
- Pessina to Build More Stakes in China, Open Pharmaciesat Bloomberg(Sat, Sep 22)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1.03 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-12)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | 1.9 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the distribution of pharmaceutical and healthcare products in the Peoples Republic of China.
View More